Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
11,023 total articles
AST SpaceMobile (ASTS) is an insurgent in space-based cellular backhaul, offering a differentiated approach - direct-to-cellphone broadband from orbit. That differentiation can win niche contracts and upside, but the company faces formidable competition from SpaceX Starlink and Amazon Kuiper. This trade idea lays out a pragmatic mid-term (45 tradin…
HubSpot shares have been punished alongside other software names amid AI-led sector anxiety, but the company’s positive free cash flow ($707.6M), manageable enterprise value ($12.02B) and improving technical setup argue for a mid-term long trade. This plan lays out a concrete entry at $243.29, a stop at $230.00 and a target of $300.00 for a mid-ter…
We upgrade Kinder Morgan (KMI) to Buy. The convergence of a sharp U.S. natural gas price spike, multi-billion-dollar pipeline and storage projects, and dependable fee-based cash flow argue for upside and resilient dividends. KMI's balance sheet and free cash flow generation give management flexibility to fund growth and return capital while preserv…
Shopify's pullback amid AI headlines is a headline-driven weakness, not a structural threat. With a $155B market cap, $2.0B in free cash flow and no net debt, the business can earn time for execution. This trade targets $143.21 from an entry of $119.34 with a stop at $105.16 over a long-term (180 trading days) holding period - a plan designed to ca…
Dolby combines predictable licensing revenue, healthy free cash flow ($386M), and low leverage (debt-to-equity 0) with a stock that is 30% below its 52-week high. At $61.44 today, a disciplined entry with a $56 stop and $80 target offers a defined-risk way to capture upside while dividends and buyback optionality underpin the thesis.
Nvidia is trading at $176.79 with a $4.35T market cap, P/E ~36 and free cash flow near $96.7B. The business still dominates AI training GPUs and data-center acceleration, and the balance sheet is pristine. Valuation is rich, but momentum, massive cash generation and low leverage create an asymmetric trade to the upside. This note lays out a long tr…
Alphabet has retraced into two clean gap zones and is sitting above its short-term averages with neutral momentum. Fundamentals - $3.61T market cap, P/E ~27, FCF $73.3B, ROE 31.8% - back a conviction buy. This trade plan targets a measured rebound into nearby resistance with controlled risk.
Assa Abloy combines recurring aftermarket revenues, high switching costs and a global footprint in an industry with structural tailwinds. This trade idea argues a long position into $45.00 with a $55.00 target and $40.00 stop, held out to 180 trading days, as a way to capture continued compounding while keeping drawdown risk controlled.
Kakula's rebuild and ramp risk have created a window where patient, disciplined longs can buy optionality on a reworked copper engine. Trade plan: enter at $3.25, stop at $2.45, target $5.50 with a long-term horizon (180 trading days). Expect volatility while underground repairs and commissioning progress through mid-2026.
Celestica has moved from cyclically cheap to genuinely strategic: a partnership to build AMD Helios networking switches, healthy free cash flow, and strong ROE argue for a conviction long. I upgrade to Buy and lay out an actionable plan for a long-term trade (180 trading days) with entry, stop, and target.
Cenovus has moved quickly to integrate MEG Energy, raise production, and prioritize debt reduction while reauthorizing a sizable buyback. With technical momentum and macro oil upside, we present a mid-term long trade that targets a breakout beyond the recent high while limiting downside with a defined stop.
One Stop Systems (OSS) is a compact edge-compute company that combines ruggedized hardware and GPU-dense platforms for defense and commercial AI at the edge. Recent contract wins, a multi-year commercial platform award, and a product portfolio built for harsh environments argue for mid-term upside. Valuation is modestly demanding on earnings but re…
Zai Lab ($ZLAB) looks positioned for a renewed growth narrative driven by newer assets (Xacduro, ZL-1310) and recent regulatory momentum in China. The balance sheet and technicals support a tactical long trade: entry near current levels, a clear stop under recent support, and a target that prices in a successful commercial/clinical cadence over the…
Lumentum (LITE) sits squarely at the optical bottleneck for AI networking. Fundamentals and recent order flows point to continued tightness in high-end optics; the market still prices much of the company as a pure-growth, science play. We see a cleaner trade: buy exposure on a mid-term time frame to capture re-rating as supply normalizes but stays …
Meta is trading well below its 52-week high and offers a durable franchise, strong cash generation ($46.1B FCF), and reasonable valuation (~24x earnings). With AI infrastructure commitments, new product cycles, and a healthy balance sheet, we see a favorable risk/reward for a long trade targeting $720 over the next 180 trading days. Entry $576.50, …
AeroVironment (AVAV) pulled back after a March earnings miss and contract turbulence but still sits on a multi-billion-dollar bookings pipeline and growing demand for counter-UAS and directed-energy systems. The stock appears to have missed the recent Middle East defense rally; this trade targets a recovery to near-term technical anchors with a dis…
TAV Havalimanlari (TAVHY) looks mispriced after a wave of panic selling and outsized short activity. The business has diversified airport revenue streams, a $2.62B market cap and technicals that favor a reversal. My trade: enter $28.50, stop $25.50, target $34.00 over a mid-term (45 trading days) horizon.
Exxon Mobil (XOM) is a high-quality cash generator trading at $160.67 with a market cap near $669B and free cash flow of roughly $23.6B. The company can thrive at $70-$110 oil, and current geopolitical risk (Iran/Strait of Hormuz) has driven crude higher; that creates an opportunity to buy the stock for a long-term trade (180 trading days) with a c…
DigitalOcean's AI inference revenue and high-value customer expansion are tracking well above historical trends. With Q4 2025 revenue of $242M, AI ARR up 150% YoY to $120M and ARR from >$1M customers up 123%, the market still appears to be discounting future monetization. This trade targets that catch-up over a 180 trading-day horizon with defined …
Arista is uniquely positioned to capture the next wave of data center networking spend driven by AI. Strong 2025 results, a $5.4B deferred revenue backlog, and FCF of $4.25B support growth guidance and a durable moat. We upgrade to a buy with an entry at $127.50, a target of $177.50, and a stop at $115.00 — horizon: long term (180 trading days).
Intel (INTC) is a pragmatic long after regaining full control of Fab 34 and amid a scenario where U.S.-Iran friction could tighten helium supply for chip fabs. Combine improved balance-sheet moves, bullish momentum and a unique foundry footprint and the risk/reward supports a targeted trade: entry $51.38, stop $45.00, target $62.00 for a long-term …
Citigroup (C) is trading at roughly $116 with a market cap near $202B, a P/E in the mid-teens and tangible near-term catalysts including an investor day and seasonal capital-markets activity. The stock looks attractively valued relative to its book value and earnings power, offering a balanced reward-to-risk setup into 2026 investor communications.…
Brookfield Asset Management just raised its distribution by 15% and continues to deploy into large deal flow (including a €1.2B Spanish multifamily purchase). At $44.47, the stock yields roughly 4.1% today — the raise pushes that toward ~4.7% — and offers a catalyst-rich setup for a mid-term swing. Valuation on cash-flow multiples is elevated, so p…
Moderna is trading at roughly $49 and a $19.4B market cap as it pivots from historic COVID revenues toward RSV, flu and oncology mRNA programs. Fundamentals remain challenged - negative EPS, negative free cash flow and a recent multi-billion-dollar legal settlement - but the stock already reflects optimism and a cleared legal overhang. This is a sp…
Energy Fuels (UUUU) owns a rare mix of U.S.-based uranium production, rare-earth progress toward separation, and medical isotope capability. With a $4.29B market cap, heavy policy catalysts in play and a stock trading well off its 52-week high, this is an actionable long idea for investors willing to accept above-average execution and balance-sheet…
